Normothermic machine perfusion of the kidney: Better conditioning and repair?

Transplant International

Volumn 28, Issue 6, 2015, Pages 657-664

  Hosgood, Sarah A ^a   Van Heurn, Ernest ^b   Nicholson, Michael L ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

ex vivo normothermic perfusion; kidney; preservation; repair; transplantation conditioning

Indexed keywords

FLUOROCARBON; VASODILATOR AGENT; PRESERVATION SOLUTION;

CENTRIFUGAL PUMP; CRYOPRESERVATION; GENE THERAPY; HUMAN; ISCHEMIC PRECONDITIONING; KIDNEY FUNCTION; KIDNEY PERFUSION; MEDICAL DEVICE; MEMBRANE OXYGENATOR; MESENCHYMAL STROMA CELL; NONHUMAN; NORMOTHERMIC MACHINE PERFUSION; PRIORITY JOURNAL; REVIEW; COLD ISCHEMIA; DEVICES; DONOR; DONOR SELECTION; ISCHEMIA; KIDNEY; KIDNEY TRANSPLANTATION; ORGAN PRESERVATION; PATHOLOGY; PERFUSION; PHYSIOLOGY; PROCEDURES; STEM CELL TRANSPLANTATION; TEMPERATURE; TRANSPLANTATION CONDITIONING;

COLD ISCHEMIA; DONOR SELECTION; GENETIC THERAPY; HUMANS; ISCHEMIA; KIDNEY; KIDNEY TRANSPLANTATION; ORGAN PRESERVATION; ORGAN PRESERVATION SOLUTIONS; PERFUSION; STEM CELL TRANSPLANTATION; TEMPERATURE; TISSUE DONORS; TRANSPLANTATION CONDITIONING;

EID: 84929332024     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/tri.12319     Document Type: Review

References (60)

1. Summers DM, Johnson RJ, Hudson A, Collett D, Watson CJ, Bradley JA,. Effect of donor age and cold storage time on outcome in recipients of kidneys donated after circulatory death in the UK: a cohort study. Lancet 2013; 381: 727.
2. Summers DM, Johnson RJ, Allen J, et al,. Analysis of factors that affect outcome after transplantation of kidneys donated after cardiac death in the UK: a cohort study. Lancet 2010; 376: 1303.
3. Rao PS, Ojo A,. The alphabet soup of kidney transplantation: SCD, DCD, ECD-fundamentals for the practicing nephrologist. Clin J Am Soc Nephrol 2009; 4: 1827.
4. Fuller BJ, Lee CY,. Hypothermic perfusion preservation: the future of organ preservation revisited? Cryobiology 2007; 54: 129.
5. Salahudeen AK,. Cold ischemic injury of transplanted kidneys: new insights from experimental studies. Am J Physiol Renal Physiol 2004; 287: F181.
6. Weinberg JM,. The cell biology of ischemic renal injury. Kidney Int 1991; 39: 476.
7. Dittrich S, Groneberg DA, von Loeper J, et al,. Influence of cold storage on renal ischemia reperfusion injury after non-heart-beating donor explantation. Nephron Exp Nephrol 2004; 96: e97.
8. Bilgin N, Karakayali H, Moray G, et al,. Outcome of renal transplantation from elderly donors. Transplant Proc 1998; 30: 744.
9. Kayler LK, Magliocca J, Zendejas I, Srinivas TR, Schold JD,. Impact of cold ischemia time on graft survival among ECD transplant recipients: a paired kidney analysis. Am J Transplant 2011; 11: 2647.
10. Sung RS, Guidinger MK, Christensen LL, et al,. Development and current status of ECD kidney transplantation. Clin Transpl 2005; 2005: 37.
11. Koetting M, Frotscher C, Minor T,. Hypothermic reconditioning after cold storage improves postischemic graft function in isolated porcine kidneys. Transpl Int 2010; 23: 538.
12. McAnulty JF,. Hypothermic organ preservation by static storage methods: current status and a view to the future. Cryobiology 2010; 60 (3 Suppl.): S13.
13. Cypel M, Yeung JC, Liu M, et al,. Normothermic ex vivo lung perfusion in clinical lung transplantation. N Engl J Med 2011; 364: 1431.
14. Tenderich G, Tsui S, El-Banayosy A, et al,. 293: the 1-year follow-up results of the PROTECT patient population using the organ care system. J Heart Lung Transplant 2008; 27 (2 Suppl.): S166.
15. Hosgood SA, Nicholson ML,. First in man renal transplantation after ex vivo normothermic perfusion. Transplantation 2011; 92: 735.
16. Brasile L, DelVecchio P, Amyot K, Haisch C, Clarke J,. Organ preservation without extreme hypothermia using an Oxygen supplemented perfusate. Artif Cells Blood Substit Immobil Biotechnol 1994; 22: 1463.
17. Brasile L, Stubenitsky BM, Booster MH, Arenada D, Haisch C, Kootstra G,. Hypothermia-a limiting factor in using warm ischemically damaged kidneys. Am J Transplant 2001; 1: 316.
18. Brasile L, Stubenitsky BM, Booster MH, et al,. The potential of repairing organs ex vivo. Transplant Proc 2002; 34: 2625.
19. Brasile L, Stubenitsky BM, Booster MH, et al,. Overcoming severe renal ischemia: the role of ex vivo warm perfusion. Transplantation 2002; 73: 897.
20. Brasile L, Stubenitsky B, Haisch CE, Kon M, Kootstra G,. Potential of repairing ischemically damaged kidneys ex vivo. Transplant Proc 2005; 37: 375.
21. Clark MC, Weiman DS, Pate JW, Gir S,. Perfluorocarbons: future clinical possibilities. J Invest Surg 1997; 10: 357.
22. Hosgood SA, Nicholson ML,. The role of perfluorocarbon in organ preservation. Transplantation 2010; 89: 1169.
23. Humphreys MR, Ereth MH, Sebo TJ, et al,. Can the kidney function as a lung? Systemic oxygenation and renal preservation during retrograde perfusion of the ischaemic kidney in rabbits. BJU Int 2006; 98: 674.
24. Daniels FH, McCabe RE Jr, Leonard EF,. The use of hemoglobin solutions in kidney perfusions. Crit Rev Biomed Eng 1984; 9: 315.
25. Stubenitsky BM, Booster MH, Brasile L, Araneda D, Haisch CE, Kootstra G,. Exsanguinous metabolic support perfusion-a new strategy to improve graft function after kidney transplantation. Transplantation 2000; 70: 1254.
26. Gage F, Leeser DB, Porterfield NK, et al,. Room temperature pulsatile perfusion of renal allografts with Lifor compared with hypothermic machine pump solution. Transplant Proc 2009; 41: 3571.
27. Olschewski P, Gass P, Ariyakhagorn V, et al,. The influence of storage temperature during machine perfusion on preservation quality of marginal donor livers. Cryobiology 2010; 60: 337.
28. Kay MD, Hosgood SA, Harper SJ, Bagul A, Waller HL, Nicholson ML,. Normothermic versus hypothermic ex vivo flush using a novel phosphate-free preservation solution (AQIX) in porcine kidneys. J Surg Res 2011; 171: 275.
29. Kay MD, Hosgood SA, Harper SJ, et al,. Static normothermic preservation of renal allografts using a novel nonphosphate buffered preservation solution. Transpl Int 2007; 20: 88.
30. Thuillier R, Dutheil D, Trieu MT, et al,. Supplementation with a new therapeutic oxygen carrier reduces chronic fibrosis and organ dysfunction in kidney static preservation. Am J Transplant 2011; 11: 1845.
31. Thiara AP, Hoel TN, Kristiansen F, Karlsen HM, Fiane AE, Svennevig JL,. Evaluation of oxygenators and centrifugal pumps for long-term pediatric extracorporeal membrane oxygenation. Perfusion 2007; 22: 323.
32. Bagul A, Hosgood SA, Kaushik M, Kay MD, Waller HL, Nicholson ML,. Experimental renal preservation by normothermic resuscitation perfusion with autologous blood. Br J Surg 2008; 95: 111.
33. Hosgood SA,. Renal transplantation after ex vivo normothermic perfusion: the first clinical study. Am J Transplant 2013; 13: 1246.
34. Saad S, Minor T,. Short-term resuscitation of predamaged donor livers by brief machine perfusion: the influence of temperature. Transplant Proc 2008; 40: 3321.
35. Bonventre JV,. Mediators of ischemic renal injury. Annu Rev Med 1988; 39: 531.
36. Bonventre JV, Yang L,. Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest 2011; 121: 4210.
37. Bonventre JV,. Complement and renal ischemia-reperfusion injury. Am J Kidney Dis 2001; 38: 430.
38. Gawaz M,. Role of platelets in coronary thrombosis and reperfusion of ischemic myocardium. Cardiovasc Res 2004; 61: 498.
39. Yang B, Hosgood SA, Harper SJ, Nicholson ML,. Leucocyte depletion improves renal function in porcine kidney hemoreperfusion through reduction of myeloperoxidase+ cells, caspase-3, IL-1beta, and tubular apoptosis. J Surg Res 2010; 164: e315.
40. Harper S, Hosgood S, Kay M, Nicholson M,. Leucocyte depletion improves renal function during reperfusion using an experimental isolated haemoperfused organ preservation system. Br J Surg 2006; 93: 623.
41. van der Wijk J, Slooff MJ, Rijkmans BG, Kootstra G,. Successful 96- and 144-hour experimental kidney preservation: a combination of standard machine preservation and newly developed normothermic ex vivo perfusion. Cryobiology 1980; 17: 473.
42. Rijkmans BG, Buurman WA, Kootstra G,. Six-day canine kidney preservation. Hypothermic perfusion combined with isolated blood perfusion. Transplantation 1984; 37: 130.
43. Hosgood SA, Patel M, Nicholson ML,. The conditioning effect of ex vivo normothermic perfusion in an experimental kidney model. J Surg Res 2013; 182: 153.
44. Hosgood SA, Barlow AD, Yates PJ, Snoeijs MG, van Heurn EL, Nicholson ML,. A pilot study assessing the feasibility of a short period of normothermic preservation in an experimental model of non heart beating donor kidneys. J Surg Res 2011; 171: 283.
45. Mallouk Y, Vayssier-Taussat M, Bonventre JV, Polla BS,. Heat shock protein 70 and ATP as partners in cell homeostasis (Review). Int J Mol Med 1999; 4: 463.
46. Brasile L, Buelow R, Stubenitsky BM, Kootstra G,. Induction of heme oxygenase-1 in kidneys during ex vivo warm perfusion. Transplantation 2003; 76: 1145.
47. Caumartin Y, Stephen J, Deng JP, et al,. Carbon monoxide-releasing molecules protect against ischemia-reperfusion injury during kidney transplantation. Kidney Int 2011; 79: 1080.
48. Hosgood SA, Bagul A, Kaushik M, Rimoldi J, Gadepalli RS, Nicholson ML,. Application of nitric oxide and carbon monoxide in a model of renal preservation. Br J Surg 2008; 95: 1060.
49. Sandovici M, Deelman LE, de Zeeuw D, van Goor H, Henning RH,. Immune modulation and graft protection by gene therapy in kidney transplantation. Eur J Pharmacol 2008; 585: 261.
50. Sandovici M, Henning RH, van Goor H, Helfrich W, de Zeeuw D, Deelman LE,. Systemic gene therapy with interleukin-13 attenuates renal ischemia-reperfusion injury. Kidney Int 2008; 73: 1364.
51. Brasile L, Stubenitsky BM, Booster MH, Arenada D, Haisch C, Kootstra G,. Transfection and transgene expression in a human kidney during ex vivo warm perfusion. Transplant Proc 2002; 34: 2624.
52. Zheng X, Zhang X, Feng B, et al,. Gene silencing of complement C5a receptor using siRNA for preventing ischemia/reperfusion injury. Am J Pathol 2008; 173: 973.
53. Yang B, Elias JE, Bloxham M, Nicholson ML,. Synthetic small interfering RNA down-regulates caspase-3 and affects apoptosis, IL-1 beta, and viability of porcine proximal tubular cells. J Cell Biochem 2011; 112: 1337.
54. Yang B, Hosgood SA, Nicholson ML,. Naked small interfering RNA of caspase-3 in preservation solution and autologous blood perfusate protects isolated ischemic porcine kidneys. Transplantation 2011; 91: 501.
55. Cantaluppi V, Biancone L, Quercia A, Deregibus MC, Segoloni G, Camussi G,. Rationale of mesenchymal stem cell therapy in kidney injury. Am J Kidney Dis 2013; 61: 300.
56. de Vries DK, Schaapherder AF, Reinders ME,. Mesenchymal stromal cells in renal ischemia/reperfusion injury. Front Immunol 2012; 3: 162.
57. Wang Y, He J, Pei X, Zhao W,. Systematic review and meta-analysis of mesenchymal stem/stromal cells therapy for impaired renal function in small animal models. Nephrology (Carlton) 2013; 18: 201.
58. Zhuo W, Liao L, Xu T, Wu W, Yang S, Tan J,. Mesenchymal stem cells ameliorate ischemia-reperfusion-induced renal dysfunction by improving the antioxidant/oxidant balance in the ischemic kidney. Urol Int 2011; 86: 191.
59. Hara Y, Stolk M, Ringe J, et al,. In vivo effect of bone marrow-derived mesenchymal stem cells in a rat kidney transplantation model with prolonged cold ischemia. Transpl Int 2011; 24: 1112.
60. Brasile L, Stubenitsky BM, Haisch CE, Kon M, Kootstra G,. Repair of damaged organs in vitro. Am J Transplant 2005; 5: 300.